Monthly Archives: September 2013

June 28 2013 – Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials

Summary Background Abnormal acid gastro-oesophageal reflux is common in patients with idiopathic pulmonary fibrosis (IPF) and is considered a risk factor for development of IPF. Retrospective studies have shown improved outcomes in patients given anti-acid treatment. The aim of this … Continue reading

Posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

June 24 2013 – Verona Pharma confirms 1st patient dosed with VRP700

StockMarketWire.com – Verona Pharma said the first patient in a clinical trial to further evaluate the efficacy of VRP700 as a novel treatment for chronic severe cough has been dosed with the drug.  It was anticipated that data from this … Continue reading

Posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

June 12 2013 – GPs urged to suspect pulmonary fibrosis in older patients with persistent cough

    NICE is urging GPs to be alert to the clinical features of idiopathic pulmonary fibrosis (IPF) and refer patients who may have the condition promptly, in new guidance aimed at speeding up diagnosis and treatment for the condition. … Continue reading

Posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , , , , | Leave a comment